clofibrate has been researched along with ascorbic acid in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (52.38) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 6 (28.57) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fossati, C | 1 |
| Odumosu, A; Wilson, CW | 2 |
| Hayashi, E; Kunitomo, M; Sato, M; Terada, M; Yamada, J | 1 |
| Hayashi, E; Kunitomo, M; Terada, M; Tomita, T; Yamada, J | 1 |
| Spittle, CR | 1 |
| Haettinger, JR; Hutsell, TC; Mackerer, CR | 1 |
| Cederbaum, AI; Rubin, E | 1 |
| Albers, JJ; Applebaum-Bowden, D; Gagne, C; Hazzard, WR; Wahl, PW; Warnick, GR | 1 |
| Odumosu, A | 1 |
| Altman, RF; Fidanza, A; Greco-Ferrante, A; Hanck, A; La Rocca, L; Odumosu, A; Wilson, CW | 1 |
| Bánhegyi, G; Braun, L; Csala, M; Kardon, T; Mandl, J; Mile, V; Schaff, Z | 1 |
| Newaz, M; Oyekan, A; Yousefipour, Z | 1 |
| Batheja, P; Michniak-Kohn, B; Song, Y; Wertz, P | 1 |
| Klevay, LM | 1 |
2 review(s) available for clofibrate and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Therapy of diabetic retinopathy].
Topics: Anabolic Agents; Anticoagulants; Ascorbic Acid; Calcium Dobesilate; Clofibrate; Cryosurgery; Diabetic Retinopathy; Humans; Hypoglycemic Agents; Hypophysectomy; Light Coagulation; Salivary Glands; Sclera | 1979 |
19 other study(ies) available for clofibrate and ascorbic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Hypocholesterolemic effects of vitamin C, clofibrate and diosgenin in male guinea-pigs [proceedings].
Topics: Animals; Anticholesteremic Agents; Ascorbic Acid; Clofibrate; Diosgenin; Guinea Pigs; Male; Sapogenins | 1979 |
Fundamental studies on physiological and pharmacological actions of L-ascorbate 2-sulfate. V. On the hypolipidemic and antiatherosclerotic effects of L-ascorbate 2-sulfate in rabbits.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Ascorbic Acid; Body Weight; Cholesterol; Clofibrate; Hypolipidemic Agents; Liver; Male; Phospholipids; Rabbits; Triglycerides | 1978 |
Vitamin C and the cholesterol-lowering effect of clofibrate [proceedings].
Topics: Animals; Anticholesteremic Agents; Ascorbic Acid; Clofibrate; Guinea Pigs; Male | 1978 |
Fundamental studies on physiological and pharmacological actions of L-ascorbate 2-sulfate. I. On the hypolipidemic effects.
Topics: Animals; Anticholesteremic Agents; Ascorbic Acid; Cholesterol; Clofibrate; Dose-Response Relationship, Drug; Female; Hypercholesterolemia; Hyperlipidemias; Lipid Metabolism; Liver; Male; Mice; Polyethylene Glycols; Rats; Sex Factors; Triglycerides | 1976 |
Atherosclerosis and vitamin C.
Topics: Adult; Age Factors; Anticoagulants; Arteriosclerosis; Ascorbic Acid; Cholesterol; Clofibrate; Female; Humans; Male; Middle Aged | 1971 |
Effects of clofibrate, in vitro, on mitochondrial respiration and oxidative phosphorylation.
Topics: Aniline Compounds; Animals; Ascorbic Acid; Butyrates; Clofibrate; Dinitrophenols; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Mitochondria, Liver; NAD; Oxidative Phosphorylation; Oxygen Consumption; Polarography; Rats; Succinates; Vibration | 1973 |
Effects of clofibrate on mitochondrial function.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Ascorbic Acid; Aspartic Acid; Calcium; Clofibrate; Energy Metabolism; Ethanol; Glycerophosphates; In Vitro Techniques; Ketoglutaric Acids; Malates; Membranes; Mitochondria, Liver; NAD; Oxidative Phosphorylation; Oxygen Consumption; Permeability; Phosphorus Radioisotopes; Rats; Succinates | 1974 |
Plasma and lipoprotein lipid responses to four hypolipid drugs.
Topics: Adult; Aged; Aminosalicylic Acid; Ascorbic Acid; Cholesterol; Clofibrate; Colestipol; Female; Humans; Hypolipidemic Agents; Lipids; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Oxandrolone; Triglycerides | 1984 |
How vitamin C, clofibrate and diosgenin control cholesterol metabolism in male guinea-pigs.
Topics: Animals; Ascorbic Acid; Cholesterol; Clofibrate; Diet; Diosgenin; Growth; Guinea Pigs; Hypercholesterolemia; Liver; Male; Sapogenins | 1982 |
Workshop on the role of vitamin C in lipid metabolism.
Topics: Animals; Arteriosclerosis; Ascorbic Acid; Clofibrate; Diet; Drug Interactions; Humans; Hypercholesterolemia; Lipid Metabolism; Nicotinic Acids; Phospholipids | 1982 |
Induction and peroxisomal appearance of gulonolactone oxidase upon clofibrate treatment in mouse liver.
Topics: Animals; Ascorbic Acid; Clofibrate; Enzyme Activation; Enzyme Induction; Hypolipidemic Agents; L-Gulonolactone Oxidase; Liver; Male; Mice; Mice, Inbred C57BL; Microsomes, Liver; Peroxisomes; RNA, Messenger; Sugar Alcohol Dehydrogenases | 1999 |
Role of PPAR-gamma on the pathogenesis and vascular changes in glycerol-induced acute renal failure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acute Kidney Injury; Angiotensin II; Animals; Ascorbic Acid; Clofibrate; Down-Regulation; Free Radicals; Glycerol; Kidney; Male; Nitric Oxide; Nitriles; PPAR gamma; Rats; Rats, Sprague-Dawley; Renal Circulation; Thiazolidinediones; Thromboxane A2; Vasoconstriction | 2006 |
Effects of growth conditions on the barrier properties of a human skin equivalent.
Topics: Anticholesteremic Agents; Ascorbic Acid; Cells, Cultured; Clofibrate; Collagen Type I; Fatty Acids; Humans; Keratinocytes; Lipids; Models, Biological; Permeability; Pharmaceutical Preparations; PPAR alpha; Skin; Skin, Artificial; Tissue Engineering | 2009 |
Cholesterotropic and cuprotropic chemicals.
Topics: Animals; Ascorbic Acid; Calcium; Cholesterol; Clofibrate; Copper; Diet; Fenofibrate; Fructose; Humans | 2020 |